Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

321 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Is pulsed saturation transfer sufficient for differentiating radiation necrosis from tumor progression in brain metastases?
Chan RW, Lam WW, Chen H, Murray L, Zhang B, Theriault A, Endre R, Moon S, Liebig P, Maralani PJ, Tseng CL, Myrehaug S, Detsky J, Lim-Fat MJ, Roberto K, Djayakarsana D, Lingamoorthy B, Mehrabian H, Khan BM, Sahgal A, Soliman H, Stanisz GJ. Chan RW, et al. Among authors: tseng cl. Neurooncol Adv. 2024 Jul 29;6(1):vdae132. doi: 10.1093/noajnl/vdae132. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 39220250 Free PMC article.
Gadolinium Enhanced T2 FLAIR is an Imaging Biomarker of Radiation Necrosis and Tumor Progression in Patients with Brain Metastases.
Heyn C, Bishop J, Moody AR, Kang T, Wong E, Howard P, Maralani P, Symons S, MacIntosh BJ, Keith J, Lim-Fat MJ, Perry J, Myrehaug S, Detsky J, Tseng CL, Chen H, Sahgal A, Soliman H. Heyn C, et al. Among authors: tseng cl. AJNR Am J Neuroradiol. 2024 Aug 6:ajnr.A8431. doi: 10.3174/ajnr.A8431. Online ahead of print. AJNR Am J Neuroradiol. 2024. PMID: 39107039
Corrigendum to "Development and functional evaluation of a hyaluronic acid coated nano-formulation with kaempferol as a novel intra-articular agent for knee osteoarthritis treatment"[ Biomed. Pharmacother. 175(2024) 116717].
Lee CY, Chang YC, Yang KC, Lin YF, Wu ATH, Tseng CL. Lee CY, et al. Among authors: tseng cl. Biomed Pharmacother. 2024 Aug;177:116944. doi: 10.1016/j.biopha.2024.116944. Epub 2024 Jun 20. Biomed Pharmacother. 2024. PMID: 38906798 Free article. No abstract available.
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy: A 9-year update.
Hudson JM, Loblaw A, McGuffin M, Chung HT, Tseng CL, Helou J, Cheung P, Szumacher E, Liu S, Zhang L, Deabreu A, Mamedov A, Morton G. Hudson JM, et al. Among authors: tseng cl. Radiother Oncol. 2024 Sep;198:110381. doi: 10.1016/j.radonc.2024.110381. Epub 2024 Jun 13. Radiother Oncol. 2024. PMID: 38879130 Free article. Clinical Trial.
NIR-Responsive Methotrexate-Modified Iron Selenide Nanorods for Synergistic Magnetic Hyperthermic, Photothermal, and Chemodynamic Therapy.
Thirumurugan S, Muthiah KS, Lin YC, Dhawan U, Liu WC, Wang AN, Liu X, Hsiao M, Tseng CL, Chung RJ. Thirumurugan S, et al. Among authors: tseng cl. ACS Appl Mater Interfaces. 2024 May 22;16(20):25622-25636. doi: 10.1021/acsami.3c18450. Epub 2024 May 13. ACS Appl Mater Interfaces. 2024. PMID: 38739745 Free PMC article.
321 results